Skip to content

The Healthcare News Network

Your daily guide to Medicare, insurance, medicines and staying well

Friday, October 30, 2026● Updated 6:00 AM ET
Daily edition

Healthcare news for October 30, 2026

New federal rule makes drug 'middlemen' show employers how they get paid The U.S. Labor Department finalized a rule that requires pharmacy benefit managers, the companies that run prescription coverage for most job-based health plans, to tell employers exactly how much money they make. For the first time, PBMs will have to disclose the payments they collect from drugmakers, pharmacies and others in the supply chain, the rebates they negotiate, and any 'spread' they keep when a plan pays more for a drug than the pharmacy receives. Employers get those reports when they sign or renew a contract and every six months after that, and they can audit them once a year. Regulators estimate the change could save employers and workers about $22 billion over 10 years. The PBM industry argues the rule duplicates existing law and may challenge it. The rule covers large self-insured employer plans, not Medicare, and takes effect in July 2027. If you have job-based coverage, nothing changes at the pharmacy counter today, but your employer will have far better information for bargaining over drug costs.

In 30 seconds

Medicare & Seniors

  • Family caregivers now spend about $11,500 a year out of pocket, AARP finds

    AARP's new study says caregivers' own spending has climbed almost 60% since 2021 and eats up about 31% of their income on average, and far more for lower-income households. Caring for someone with dementia costs more, about $15,800 a year. Most of the money goes to housing, household bills and medical costs. AARP is pushing Congress for caregiver tax credits and other relief.

    AARP
  • Medicare proposes protection when a plan's doctor list is wrong

    CMS reviews found errors in about 44% of Medicare Advantage directory listings. A new proposal would make plans check their directories every 90 days and remove departed doctors within five business days starting in 2028. If a plan listed a doctor as in-network when you booked but they weren't when you were seen, you'd pay only the in-network share. Comments are due Dec. 15.

    American Academy of Ophthalmology
  • Centene sues Medicare over star ratings it says cost $448 million

    Centene, which runs Wellcare plans, says CMS used 17 measures that a court already rejected in another insurer's case when scoring its 2027 Medicare Advantage ratings. It wants the ratings redone and low-rating warnings removed from two contracts on Medicare Plan Finder. No court has ruled yet.

    Insurance Business

Insurance & ACA

  • What to know before ACA shopping opens Sunday

    Premiums are set to rise about 15% on average for 2027, and subsidies stop for households earning above four times the poverty level, about $63,840 for a single person. The most you can owe out of pocket in a year climbs to $12,000 for an individual. On HealthCare.gov, some people, including first-time applicants, will need to verify their identity themselves. Don't let your plan simply renew; compare options.

    KFF Health News
  • Fewer employers are covering GLP-1 weight-loss drugs

    A WTW survey of 471 employers found coverage of drugs like Wegovy and Zepbound for weight loss fell to 53% from 57%, and nearly a third of those still covering them are thinking about stopping. Employers expect health costs to jump 9.7% next year. If your plan is dropping these drugs, ask about appeals or the drugmakers' lower self-pay prices.

    Medical Daily

Medicines & FDA

  • Lilly's experimental 'triple' drug beats Ozempic in a big diabetes trial

    In a 1,298-person study, people taking retatrutide lost about 20% of their body weight over 80 weeks, roughly twice as much as with semaglutide, and saw bigger drops in blood sugar. More people quit retatrutide because of side effects. The drug is not approved yet, and Lilly hasn't given an approval timeline.

    AJMC
  • Miyoko's plant-based butter recalled over mold, yeast and E. coli concerns

    More than 1,300 cases of 8-ounce European Style Salted Plant Milk Butter were recalled in 10 states, including Florida, Georgia, Illinois and New Jersey. Look for lot 07871 with a Nov. 5, 2026 best-by date and throw it out or return it. The FDA rated the risk as moderate (Class II), and it's unclear whether anyone got sick.

    ABC News

Staying Well

Policy & Law

Hospitals & Business